Acadia Pharmaceuticals Inc. (DR6)

Market Open

3 Dec, 07:01

XFRA

€

19. 88

- Market Cap

- P/E Ratio

0% Div Yield

0 Volume

-0.34 Eps

€ 19.88

Previous Close

Day Range

19.88 19.88

Year Range

12.47 22.77

Want to track DR6 and more in your Portfolio? 🎯

Get Started For Free

Earnings results expected in 82 days

Overview
Earnings

DR6 Acadia Pharmaceuticals Inc. 25 Feb 2026 (In 2 months)	0.15 Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 5 Nov 2025	0.15 Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 4 Nov 2025	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 4 Aug 2025	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 6 May 2025	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 25 Feb 2025	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 31 Oct 2024	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 31 Jul 2024	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 29 May 2024	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 8 May 2024	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 27 Feb 2024	- Cons. EPS	- EPS
DR6 Acadia Pharmaceuticals Inc. 2 Nov 2023	- Cons. EPS	- EPS

DR6 Earnings Reports FAQ

What is the earnings per share (EPS) for DR6?

The current EPS is -0.34.

What is the company's earnings growth rate?

Acadia Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-25, based on the DR6's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Acadia Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for DR6 at this time, as Acadia Pharmaceuticals Inc has no recent EPS data to calculate it.

Affiliate Program About Terms Privacy Help Contact Us